Literature DB >> 21858428

The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients.

Jose A Meneses1, Fernando M Lucas, Fernando C Assunção, Junia P P Castro, Rogério B Monteiro.   

Abstract

A total of 150 patients were included in the analysis. Through chart review, we estimated glomerular filtration rate in the first visit and, at least, 5 years later. All patients were divided into two groups: (1) metaphylaxis adherents (n = 74) and (2) metaphylaxis non-adherents (n = 76). We followed all patients for at least 5 years. The Scr percentage of patients and GFR <60 mL/min was compared between groups. Variables were compared between groups using t test, χ(2) tests, odds ratios with 95% confidence intervals. There were no differences at baseline between groups. After 5 years of follow-up, GFR was 77.9 mL/min in non-adherent-metaphylaxis group and in the adherent-metaphylaxis group was 87.3 mL/min, with p value of 0.02. After 5 years of follow-up, we had a GFR <60 mL/min in the adherent-metaphylaxis group (4.89 vs. 21.95%) with p value of 0.001 and OR = 5.36; IC-95% = 1.95-14.8. Metaphylaxis of kidney stone disease could prevent chronic kidney disease.

Entities:  

Mesh:

Year:  2011        PMID: 21858428     DOI: 10.1007/s00240-011-0407-5

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  31 in total

Review 1.  Epidemiology of stone disease.

Authors:  Gary C Curhan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

2.  Morphological lesions of the rat urinary tract induced by inoculation of mycoplasmas and other urinary tract pathogens.

Authors:  P A Larsson; M Cano; L Grenabo; J E Brorson; H Hedelin; S Pettersson; S L Johansson
Journal:  Urol Int       Date:  1989       Impact factor: 2.089

Review 3.  Nephrocalcinosis in animal models with and without stones.

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2010-07-24

4.  ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.

Authors:  Paul Jungers; Dominique Joly; Frédéric Barbey; Gabriel Choukroun; Michel Daudon
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

5.  Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Authors:  B Ettinger; A Tang; J T Citron; B Livermore; T Williams
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

6.  Oxalate toxicity in LLC-PK1 cells: role of free radicals.

Authors:  C Scheid; H Koul; W A Hill; J Luber-Narod; L Kennington; T Honeyman; J Jonassen; M Menon
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

7.  X-linked recessive nephrolithiasis with renal failure.

Authors:  P A Frymoyer; S J Scheinman; P B Dunham; D B Jones; P Hueber; E T Schroeder
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

8.  Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.

Authors:  B Ettinger; J T Citron; B Livermore; L I Dolman
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

9.  Primary hyperoxaluria: an important cause of renal failure in infancy.

Authors:  E P Leumann
Journal:  Int J Pediatr Nephrol       Date:  1985 Jan-Mar

10.  TWO CASES OF PRIMARY OXALOSIS.

Authors:  J W KOTEN; E J MEES; L W HOLLEMAN; R D SCHUILING
Journal:  J Clin Pathol       Date:  1965-03       Impact factor: 3.411

View more
  3 in total

Review 1.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

2.  Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.

Authors:  Harald Seeger; Andrea Kaelin; Pietro M Ferraro; Damian Weber; Philippe Jaeger; Patrice Ambuehl; William G Robertson; Robert Unwin; Carsten A Wagner; Nilufar Mohebbi
Journal:  BMC Nephrol       Date:  2017-12-04       Impact factor: 2.388

3.  The efficacy of metaphylaxis in treatment of recurrent urolithiasis.

Authors:  P Banov; E Ceban
Journal:  J Med Life       Date:  2017 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.